UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.)
|
Filed by the Registrant ☒
|
|
|
Filed by a Party other than the Registrant ☐
|
Check the appropriate box:
|
☐
|
|
|
Preliminary Proxy Statement
|
|
☐
|
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☐
|
|
|
Definitive Proxy Statement
|
|
☒
|
|
|
Definitive Additional Materials
|
|
☐
|
|
|
Soliciting Material under §240.14a-12
|
WEREWOLF THERAPEUTICS, INC.
(Name of registrant as specified in its charter)
(Name of person(s) filing proxy statement, if other than the registrant)
Payment of Filing Fee (Check the appropriate box):
|
☒
|
|
|
No fee required
|
|
☐
|
|
|
Fee paid previously with preliminary materials
|
|
☐
|
|
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
Your Vote Counts! WEREWOLF THERAPEUTICS, INC. 200 TALCOTT AVENUE WATERTOWN, MA 02472 WEREWOLF THERAPEUTICS, INC. 2023 Annual Meeting Vote by June 20, 2023 11:59 PM ET You invested in
WEREWOLF THERAPEUTICS, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on
June 21, 2023. Vote Virtually at the Meeting* June 21, 2023 9:00 AM EDT Virtually at: www.virtualshareholdermeeting.com/HOWL2023 *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your
camera here and vote without entering a control number V1.1 For complete information and to vote, visit www.ProxyVote.com Control # V13899-P89902 Get informed before you vote View the Notice and Proxy Statement and 2022 Annual Report online OR you
can receive a free paper or email copy of the material(s) by requesting prior to June 7, 2023. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call
1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these
important matters. Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V13900-P89902 01) Meeta Chatterjee, Ph.D. 02) Derek DiRocco,
Ph.D. 03) Daniel J. Hicklin, Ph.D. 1. Election of three directors to serve as Class II directors, each for a three-year term expiring at the 2026 Annual Meeting of Stockholders. Nominees: 2. Ratification of the appointment of Ernst & Young LLP
as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. NOTE: Such other business as may properly come before the meeting or any adjournment thereof. For For